drugset / Trial / NCT01521845

Study of the Effect of omega3 on Biomarkers of Cardiac Necrosis (CKMB and Troponin I) and Inflammation Marker (CRP) After Elective Percutaneous Coronary Intervention (PCI)

NCT01521845

Phase 3 Completed 104 enrolled Shahid Beheshti University of Medical Sciences
RandomizedParallel-groupSingle-blindPrevention

Summary

The purpose of this study is to investigate the effect of omega 3 on biomarkers of cardiac necrosis(CKMB and troponin I) and inflammation marker CRP.

Timeline

Start
2012-01
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omega-3 fatty acids Unknown 3 g